BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 22447257)

  • 1. Portopulmonary hypertension.
    Krowka MJ
    Semin Respir Crit Care Med; 2012 Feb; 33(1):17-25. PubMed ID: 22447257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portopulmonary hypertension: an update.
    Safdar Z; Bartolome S; Sussman N
    Liver Transpl; 2012 Aug; 18(8):881-91. PubMed ID: 22674534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical aspects of portopulmonary hypertension.
    Medarov BI; Chopra A; Judson MA
    Respir Med; 2014 Jul; 108(7):943-54. PubMed ID: 24816204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portopulmonary hypertension: Still an appropriate consideration for liver transplantation?
    Verma S; Hand F; Armstrong MJ; de Vos M; Thorburn D; Pan T; Klinck J; Westbrook RH; Auzinger G; Bathgate A; Masson S; Holt A; Houlihan DD; Ferguson JW
    Liver Transpl; 2016 Dec; 22(12):1637-1642. PubMed ID: 27593213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up of portopulmonary hypertension patients after liver transplantation.
    Khaderi S; Khan R; Safdar Z; Stribling R; Vierling JM; Goss JA; Sussman NL
    Liver Transpl; 2014 Jun; 20(6):724-7. PubMed ID: 24648168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portopulmonary hypertension: short review.
    Stauber RE; Olschewski H
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):385-90. PubMed ID: 19907338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Portopulmonary hypertension: survival and prognostic factors.
    Le Pavec J; Souza R; Herve P; Lebrec D; Savale L; Tcherakian C; Jaïs X; Yaïci A; Humbert M; Simonneau G; Sitbon O
    Am J Respir Crit Care Med; 2008 Sep; 178(6):637-43. PubMed ID: 18617641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary vascular abnormalities in cirrhosis.
    Herve P; Le Pavec J; Sztrymf B; Decante B; Savale L; Sitbon O
    Best Pract Res Clin Gastroenterol; 2007; 21(1):141-59. PubMed ID: 17223502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portopulmonary Hypertension: Management and Liver Transplantation Evaluation.
    DuBrock HM
    Chest; 2023 Jul; 164(1):206-214. PubMed ID: 36649754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What's new in the treatment of portopulmonary hypertension?
    DuBrock HM; Channick RN; Krowka MJ
    Expert Rev Gastroenterol Hepatol; 2015 Jul; 9(7):983-92. PubMed ID: 25882070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current management approaches to portopulmonary hypertension.
    Savale L; O'Callaghan DS; Magnier R; Le Pavec J; Hervé P; Jaïs X; Seferian A; Humbert M; Simonneau G; Sitbon O
    Int J Clin Pract Suppl; 2011 Jan; (169):11-8. PubMed ID: 21176011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in portopulmonary hypertension: Outcomes of the United Kingdom National Pulmonary Arterial Hypertension Registry.
    Sithamparanathan S; Nair A; Thirugnanasothy L; Coghlan JG; Condliffe R; Dimopoulos K; Elliot CA; Fisher AJ; Gaine S; Gibbs JSR; Gatzoulis MA; E Handler C; Howard LS; Johnson M; Kiely DG; Lordan JL; Peacock AJ; Pepke-Zaba J; Schreiber BE; Sheares KKK; Wort SJ; Corris PA;
    J Heart Lung Transplant; 2017 Jul; 36(7):770-779. PubMed ID: 28190786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving dilemmas and management of portopulmonary hypertension.
    Krowka MJ
    Semin Liver Dis; 2006 Aug; 26(3):265-72. PubMed ID: 16850376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical characteristics, treatment, and survival of portopulmonary hypertension in Japan.
    Takahashi Y; Yamamoto K; Sakao S; Takeuchi T; Suda R; Tanabe N; Tatsumi K
    BMC Pulm Med; 2021 Mar; 21(1):89. PubMed ID: 33726742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute and long-term effects of inhaled iloprost in portopulmonary hypertension.
    Melgosa MT; Ricci GL; García-Pagan JC; Blanco I; Escribano P; Abraldes JG; Roca J; Bosch J; Barberà JA
    Liver Transpl; 2010 Mar; 16(3):348-56. PubMed ID: 20209595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasomodulators and Liver Transplantation for Portopulmonary Hypertension: Evidence From a Systematic Review and Meta-Analysis.
    Deroo R; Trépo E; Holvoet T; De Pauw M; Geerts A; Verhelst X; Colle I; Van Vlierberghe H; Fallon MB; Raevens S
    Hepatology; 2020 Nov; 72(5):1701-1716. PubMed ID: 32017176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcome in liver transplantation candidates with portopulmonary hypertension.
    Savale L; Sattler C; Coilly A; Conti F; Renard S; Francoz C; Bouvaist H; Feray C; Borentain P; Jaïs X; Montani D; Parent F; O'Connell C; Hervé P; Humbert M; Simonneau G; Samuel D; Calmus Y; Duvoux C; Durand F; Duclos-Vallée JC; Sitbon O
    Hepatology; 2017 May; 65(5):1683-1692. PubMed ID: 27997987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Portopulmonary hypertension.
    Cartin-Ceba R; Krowka MJ
    Clin Liver Dis; 2014 May; 18(2):421-38. PubMed ID: 24679504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hypertension in liver transplant.
    Ayoub T
    Curr Opin Organ Transplant; 2011 Jun; 16(3):331-7. PubMed ID: 21519260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Waitlist Mortality in Portopulmonary Hypertension.
    DuBrock HM; Goldberg DS; Sussman NL; Bartolome SD; Kadry Z; Salgia RJ; Mulligan DC; Kremers WK; Kawut SM; Krowka MJ; Channick RN
    Transplantation; 2017 Jul; 101(7):1609-1615. PubMed ID: 28207639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.